These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10228778)

  • 1. Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological features.
    Olsson R; Broomé U; Danielsson A; Hägerstrand I; Järnerot G; Lööf L; Prytz H; Rydén BO
    Hepatogastroenterology; 1999; 46(25):136-41. PubMed ID: 10228778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography.
    Enns R; Eloubeidi MA; Mergener K; Jowell PS; Branch MS; Baillie J
    Can J Gastroenterol; 2003 Apr; 17(4):243-8. PubMed ID: 12704468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatobiliary dysfunction in patients with ulcerative colitis.
    Aitola P; Karvonen AL; Matikainen M
    Ann Chir Gynaecol; 1994; 83(4):275-8. PubMed ID: 7733609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group.
    van Hoogstraten HJ; Vleggaar FP; Boland GJ; van Steenbergen W; Griffioen P; Hop WC; van Hattum J; van Berge Henegouwen GP; Schalm SW; van Buuren HR
    Am J Gastroenterol; 2000 Aug; 95(8):2015-22. PubMed ID: 10950051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary sclerosing cholangitis in common variable immune deficiency.
    Mahdavinia M; Mirsaeidi M; Bishehsari F; McGrath K
    Allergol Int; 2015 Apr; 64(2):187-9. PubMed ID: 25838096
    [No Abstract]   [Full Text] [Related]  

  • 7. The patient with unexplained elevated serum liver enzymes.
    Holstege A; Zolinski P; Woidy L; Permanetter W
    Best Pract Res Clin Gastroenterol; 2007; 21(3):535-50. PubMed ID: 17544116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study.
    Vleggaar FP; Monkelbaan JF; van Erpecum KJ
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):688-92. PubMed ID: 18679073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral budesonide in the treatment of primary sclerosing cholangitis.
    Angulo P; Batts KP; Jorgensen RA; LaRusso NA; Lindor KD
    Am J Gastroenterol; 2000 Sep; 95(9):2333-7. PubMed ID: 11007238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic.
    Davies YK; Cox KM; Abdullah BA; Safta A; Terry AB; Cox KL
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):61-7. PubMed ID: 18607270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of primary sclerosing cholangitis.
    Björnsson E
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary sclerosing cholangitis.
    Rodriguez HJ; Bass NM
    Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant strictures in patients with primary sclerosing cholangitis.
    Björnsson E; Lindqvist-Ottosson J; Asztely M; Olsson R
    Am J Gastroenterol; 2004 Mar; 99(3):502-8. PubMed ID: 15056092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
    Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
    Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis.
    Bharucha AE; Jorgensen R; Lichtman SN; LaRusso NF; Lindor KD
    Am J Gastroenterol; 2000 Sep; 95(9):2338-42. PubMed ID: 11007239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study.
    Olsson R; Boberg KM; de Muckadell OS; Lindgren S; Hultcrantz R; Folvik G; Bell H; Gangsøy-Kristiansen M; Matre J; Rydning A; Wikman O; Danielsson A; Sandberg-Gertzén H; Ung KA; Eriksson A; Lööf L; Prytz H; Marschall HU; Broomé U
    Gastroenterology; 2005 Nov; 129(5):1464-72. PubMed ID: 16285948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary sclerosing cholangitis. A report of 2 cases and review of the literature].
    dos Santos LF; de Godoy JA
    Arq Gastroenterol; 1989; 26(1-2):17-24. PubMed ID: 2574972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.
    Mendes FD; Jorgensen R; Keach J; Katzmann JA; Smyrk T; Donlinger J; Chari S; Lindor KD
    Am J Gastroenterol; 2006 Sep; 101(9):2070-5. PubMed ID: 16879434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic failure after injury - a common pathogenesis with sclerosing cholangitis?
    Zilkens C; Friese J; Köller M; Muhr G; Schinkel C
    Eur J Med Res; 2008 Jul; 13(7):309-13. PubMed ID: 18700186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective single-center review of primary sclerosing cholangitis in children.
    Miloh T; Arnon R; Shneider B; Suchy F; Kerkar N
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):239-45. PubMed ID: 19121649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.